Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022224

Expand all

TRILIPIX (CHOLINE FENOFIBRATE)
EQ 45MG FENOFIBRIC ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued

Active Ingredient: CHOLINE FENOFIBRATE
Proprietary Name: TRILIPIX
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: EQ 45MG FENOFIBRIC ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022224
Product Number: 001
Approval Date: Dec 15, 2008
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRILIPIX (CHOLINE FENOFIBRATE)
EQ 135MG FENOFIBRIC ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued

Active Ingredient: CHOLINE FENOFIBRATE
Proprietary Name: TRILIPIX
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: EQ 135MG FENOFIBRIC ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022224
Product Number: 002
Approval Date: Dec 15, 2008
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Discontinued
Patent and Exclusivity Information